title: Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.
abstract: Dendritic cells (DCs) are required for the initiation of primary immune responses. The pattern of Toll-like receptor (TLR) expression on various subsets of these cells has been shown to differ, suggestive of distinct roles in influencing immune responses. We have examined here the responses of immature DCs derived from murine bone marrow (BMDCs) to a range of TLR ligands. BMDCs cultured for 6 days in the presence of granulocyte-macrophage colony-stimulating factor were stimulated for 24 hr with ligands to TLR1-2 [Pam(3)Cys-Ser-(Lys)(4) (PAM)], TLR2-6 (macrophage-activating lipopeptide-2 (MALP-2); zymosan or peptidoglycan (PG)], TLR3 (polyinosinic-polycytidylic acid), TLR4 [lipopolysaccharide R515 (LPS)], TLR5 (flagellin), TLR7 (polyuridylic acid) and TLR9 [CpG ODN2395 (CpG)]. DC activation was monitored using membrane marker expression and analysis of culture supernatants for cytokine/chemokine release. Ligands to TLR3 and TLR7 failed to activate BMDCs. All other TLR ligands caused elevated expression of membrane markers. PAM, MALP-2 and LPS induced high-level expression of proinflammatory cytokines and chemokines. Treatment with CpG was associated with a preferential type 1 cytokine and chemokine profile. Zymosan and PG were proinflammatory but also skewed towards a type 2 pattern of cytokines and chemokines. In contrast, flagellin did not cause marked secretion by BMDCs of cytokines or chemokines. These data for BMDCs are largely consistent with the reported TLR repertoire of freshly isolated murine Langerhans cells. In addition, murine BMDCs show selective responses to TLR ligands with respect to general activation, with differentiated cytokine patterns suggestive of potential priming for divergent immune responses.
authors.affiliation: Faculty of Life Sciences, University of Manchester, Manchester, UK. rebecca.dearman@manchester.ac.uk
authors.forename: Rebecca J
authors.initials: RJ
authors.lastname: Dearman
authors.forename: Marie
authors.initials: M
authors.lastname: Cumberbatch
authors.forename: Gavin
authors.initials: G
authors.lastname: Maxwell
authors.forename: David A
authors.initials: DA
authors.lastname: Basketter
authors.forename: Ian
authors.initials: I
authors.lastname: Kimber
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000276:immunology; D002454:Cell Differentiation / Q000276:immunology; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D016130:Immunophenotyping; D008024:Ligands; D008070:Lipopolysaccharides / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D051193:Toll-Like Receptors / Q000378:metabolism*
chemical_list: D016207:Cytokines; D008024:Ligands; D008070:Lipopolysaccharides; D051193:Toll-Like Receptors
references.citation: J Immunol. 2004 Aug 15;173(4):2780-91
references.pmid: 15294997
references.citation: Biochem Biophys Res Commun. 2003 Jul 4;306(3):674-9
references.pmid: 12810071
references.citation: J Immunol Methods. 1999 Feb 1;223(1):77-92
references.pmid: 10037236
references.citation: J Immunol. 1998 Feb 15;160(4):1666-76
references.pmid: 9469423
references.citation: J Immunol. 2006 Dec 1;177(11):7959-67
references.pmid: 17114468
references.citation: J Immunol. 2000 May 15;164(10):5113-9
references.pmid: 10799868
references.citation: Nat Rev Immunol. 2006 Jan;6(1):33-43
references.pmid: 16341139
references.citation: J Immunol. 2007 Nov 1;179(9):5811-8
references.pmid: 17947654
references.citation: Immunology. 2008 Jul;124(3):329-38
references.pmid: 18194273
references.citation: Antimicrob Agents Chemother. 2005 Oct;49(10):3991-6
references.pmid: 16189071
references.citation: Mol Immunol. 2007 Mar;44(7):1483-9
references.pmid: 17052755
references.citation: J Immunol. 2003 May 15;170(10):5165-75
references.pmid: 12734364
references.citation: Scand J Immunol. 2000 Jun;51(6):586-94
references.pmid: 10849369
references.citation: Int Immunol. 2002 May;14(5):433-44
references.pmid: 11978773
references.citation: Infect Immun. 2003 Jun;71(6):3337-42
references.pmid: 12761116
references.citation: Nat Immunol. 2006 Aug;7(8):868-74
references.pmid: 16829963
references.citation: J Immunol. 2003 Apr 15;170(8):4102-10
references.pmid: 12682240
references.citation: Semin Immunol. 2004 Feb;16(1):27-34
references.pmid: 14751761
references.citation: Trends Immunol. 2006 Mar;27(3):132-9
references.pmid: 16458606
references.citation: Annu Rev Immunol. 1991;9:271-96
references.pmid: 1910679
references.citation: Infect Immun. 2005 Oct;73(10):6763-70
references.pmid: 16177354
references.citation: J Biol Chem. 2001 Oct 5;276(40):37692-9
references.pmid: 11477091
references.citation: Infect Immun. 2002 Dec;70(12):6638-45
references.pmid: 12438336
references.citation: J Leukoc Biol. 2005 Oct;78(4):888-97
references.pmid: 16033815
references.citation: Curr Mol Med. 2003 Dec;3(8):759-71
references.pmid: 14682496
references.citation: Toxicol In Vitro. 2004 Apr;18(2):195-202
references.pmid: 14757110
references.citation: J Exp Med. 1992 Dec 1;176(6):1693-702
references.pmid: 1460426
references.citation: Immunology. 2006 Jun;118(2):250-6
references.pmid: 16771860
references.citation: J Immunol. 2007 Nov 15;179(10):6830-5
references.pmid: 17982073
references.citation: J Immunol. 2006 Dec 1;177(11):7551-8
references.pmid: 17114424
references.citation: Eur J Immunol. 2004 Mar;34(3):899-907
references.pmid: 14991620
references.citation: J Invest Dermatol. 2005 Feb;124(2):343-50
references.pmid: 15675953
references.citation: Immunity. 2005 Dec;23(6):611-20
references.pmid: 16356859
references.citation: Nature. 1992 Nov 19;360(6401):258-61
references.pmid: 1279441
references.citation: J Invest Dermatol. 2004 Jan;122(1):95-102
references.pmid: 14962096
references.citation: Semin Immunol. 2005 Aug;17(4):273-83
references.pmid: 15953735
references.citation: J Immunol. 2004 Mar 1;172(5):2739-43
references.pmid: 14978071
references.citation: Biochem Biophys Res Commun. 2004 Jul 2;319(3):832-9
references.pmid: 15184058
references.citation: Immunol Res. 2006;36(1-3):127-36
references.pmid: 17337773
references.citation: J Immunol. 2001 Nov 1;167(9):5067-76
references.pmid: 11673516
references.citation: J Immunol. 2006 Jul 1;177(1):298-305
references.pmid: 16785525
references.citation: Science. 2004 Mar 5;303(5663):1529-31
references.pmid: 14976261
references.citation: J Immunol. 2007 Feb 15;178(4):1986-90
references.pmid: 17277101
references.citation: Biochem Biophys Res Commun. 2007 Oct 5;361(4):1012-6
references.pmid: 17679142
references.citation: Cell Immunol. 2007 Feb;245(2):70-9
references.pmid: 17507001
references.citation: J Immunol Methods. 1996 Sep 27;196(2):121-35
references.pmid: 8841451
references.citation: J Immunol. 2000 Dec 15;165(12):6743-7
references.pmid: 11120793
references.citation: J Immunol. 2003 Nov 15;171(10):4984-9
references.pmid: 14607893
references.citation: J Immunol. 2005 Oct 15;175(8):5146-51
references.pmid: 16210618
references.citation: J Biol Chem. 2006 Oct 13;281(41):31002-11
references.pmid: 16880211
references.citation: J Cell Biol. 2005 May 23;169(4):569-76
references.pmid: 15897263
references.citation: J Immunol. 2004 Jun 1;172(11):6922-30
references.pmid: 15153511